An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine-Reference-Cited by-同舟云学术

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

Published:2006-04-12 Issue:16 Volume:24 Page:3063-3065
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

GIUDICE G,HILBERT A,BUGARINI R,MINUTELLO A,POPOVA O,TONEATTO D,SCHOENDORF I,BORKOWSKI A,RAPPUOLI R,PODDA A

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of Enhanced Influenza Vaccines Against Mismatched Influenza Strains in Older Adults: A Review of Randomized Controlled Trials;Influenza and Other Respiratory Viruses;2024-04

2. Immunosenescence and Inflamm-Aging: Clinical Interventions and the Potential for Reversal of Aging;Cureus;2024-01-31

3. Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN);Vaccine;2023-10

4. Resolving adjuvant mode of action to enhance vaccine efficacy;Current Opinion in Immunology;2022-08

5. Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial;Vaccine;2022-08